Invention Grant
- Patent Title: Pyrazine derivatives and use as PI3K inhibitors
- Patent Title (中): 吡嗪衍生物并用作PI3K抑制剂
-
Application No.: US13222072Application Date: 2011-08-31
-
Publication No.: US08877757B2Publication Date: 2014-11-04
- Inventor: Pascale Gaillard , Anna Quattropani , Vincent Pomel , Thomas Rueckle , Jasna Klicic , Dennis Church
- Applicant: Pascale Gaillard , Anna Quattropani , Vincent Pomel , Thomas Rueckle , Jasna Klicic , Dennis Church
- Applicant Address: CH Coinsins, Vaud
- Assignee: Merck Serono SA
- Current Assignee: Merck Serono SA
- Current Assignee Address: CH Coinsins, Vaud
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP05107838 20050826
- Main IPC: A01N43/58
- IPC: A01N43/58 ; A01N43/60 ; A61K31/50 ; A61K31/495 ; C07D471/00 ; C07D403/12 ; C07D405/12 ; C07D241/44 ; C07D471/04 ; C07D407/12 ; C07D409/12 ; C07D401/12 ; C07D417/12 ; C07D413/12
Abstract:
The present invention is related to pyrazine derivatives of Formula (I) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.
Public/Granted literature
- US20110312960A1 PYRAZINE DERIVATIVES AND USE AS PI3K INHIBITORS Public/Granted day:2011-12-22
Information query
IPC分类:
